Pharmacists should make care homes aware of the recommended 7 day interval (before and after) between administration of COVID-19 vaccines and other vaccines.
Pharmacists should be aware of the 21 day interval between COVID-19 vaccination doses and arrange pharmacy influenza vaccination clinics around this.
The COVID-19 Vaccination Programme has started within Care homes, via the Trust Mobile Units and the schedule has been made available for your information.
As the schedule is subject to change it is recommended the pharmacy contact the Care home to ensure any influenza vaccination clinics can continue as planned and that the recommended interval between administration of COVID-19 vaccines and Influenza vaccines is being adhered to.
Yours sincerely
Vanessa
SENT FOR AND BEHALF OF DR. VANESSA CHAMBERS |Head of Policy & Development
Dear Colleague
Please find here correspondence for your attention from Kathryn Turner, Pharmacy Lead, HSCB.
The correspondence provides an update in relation to pharmacy services that are in place to support Care Homes at this time i.e. the existing Advice to Nursing and Residential Care Homes Service and a new Care Home Pandemic Support Service enhancement.
Those community pharmacies currently contracted with HSCB to provide the ‘Advice to Nursing and Residential Care Homes’ service to individual Care Homes should continue to submit claims as usual. It is accepted that while some aspects of the service such as the on-site visits to Care homes cannot take place at this present time, a level of service is being provided and payments will therefore continue.
It is recognised that the existing service Advice to Nursing and Residential Care Homes Service no longer meets the medicine management needs of Care homes and HSCB, CPNI and DoH will work to establish a revised service in 2021.
The aim of the new Care Home Pandemic Support Service enhancement is to ensure that nursing and residential care homes receive an enhanced level of pharmaceutical advice and support during the pandemic period from the community pharmacist, particularly at times when on-site visits are not possible. This support will help nursing and residential care homes ensure the safe handling and correct administration of drugs/medicines supplied to their residents during the COVID19 pandemic. The additional service will operate from December 2020 to March 2021.
Funding for the new service enhancement is dependent on the number of beds in the registered care home. Payment will be paid on a monthly basis on receipt of the returned contract to your local office.
Action Required
All contractors wishing to participate in this service, shouldreturn a completed contract to your local office as soon as possible. Please note all Nursing and Residential Care Homes which will be supported by the community pharmacy should be listed on the contract.
Contractors should read the enclosed service specification carefully and ensure that all relevant staff are trained and competent to deliver this service. Service documentation is also available on the BSO website at http://www.hscbusiness.hscni.net/services/2271.htm
A HSCB communication to Care Homes will advise them of this service. If you have any query about this service, please contact your local HSCB office.
Yours sincerely
Vanessa
SENT FOR AND BEHALF OF DR. VANESSA CHAMBERS | Head of Policy & Development
Dear Colleague
Please find correspondence here for your information from Rodney Morton, Director of Nursing, Midwifery and Allied Health Professionals, PHA.
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
The Department of Health (NI) has asked us to make pharmacy contractors aware of the UK-wide Ask for ANI (Action Needed Immediately) Codeword Scheme which will be launched nationally in early January.
This domestic abuse codeword scheme is being established in pharmacies to enable victims of domestic abuse to access support within their community, from the safety of their local pharmacy.
Contractors wishing to participate in the scheme may access training materials and posters at the given links (Ask for ANI materials / Ask for ANI & Safe Spaces materials) and are asked to complete an online form to confirm their decision to provide the scheme and to ensure that staff watch the training animation and read the guidance.
Yours sincerely
Vanessa
SENT FOR AND BEHALF OF DR VANESSA CHAMBERS | Head of Policy & Development
Dear Colleague
Please see correspondence here from Dr Michael McBride, Chief Medical Officer; Professor Charlotte McArdle, Chief Nursing Officer; and Cathy Harrison, Chief Pharmaceutical Officer.
Yours sincerely
SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.